Luke Moore
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance 55
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 23
-
- Nosocomial Infections in ICU 10
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies 11
- Antimicrobial Resistance in Staphylococcus 8
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 22
-
- Antibiotics Pharmacokinetics and Efficacy 15
-
- Pneumonia and Respiratory Infections 9
- Co-authors
- Alison HolmesTimothy M. RawsonPhilippe J. GuérinLaura J. V. PiddockAbhilasha KarkeySadie RegmiArnfinn SundsfjordMartin Steinbakk
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- Journal of Antimicrobial Chemotherapy (10 papers)Journal of Hospital Infection (6 papers)Clinical Microbiology and Infection (6 papers)
- Partner nations
- United KingdomUnited StatesSouth Africa
In The Last Decade
Luke Moore
134 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Applied Microbiology and Biotechnology 2.6k
- Molecular Medicine 1.4k
- Critical Care and Intensive Care Medicine 498
- Infectious Diseases 1.7k
- Clinical Biochemistry 570
Countries citing papers authored by Luke Moore
This map shows the geographic impact of Luke Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Moore more than expected).
Fields of papers citing papers by Luke Moore
This network shows the impact of papers produced by Luke Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Moore. The network helps show where Luke Moore may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luke Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 25 | |
| 13 | 2019 | 10 | |
| 14 | 2019 | 41 | |
| 15 | 2016 | 11 | |
| 16 | 2016 | 9 | |
| 17 | 2015 | 58 | |
| 18 | 2014 | 3 | |
| 19 | 2013 | 1 | |
| 20 | 2012 | 1 |
About Luke Moore
Luke Moore is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 142 papers that have together received 6.3k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (55 papers), Antibiotic Resistance in Bacteria (23 papers), Bacterial Identification and Susceptibility Testing (22 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), COVID-19 Clinical Research Studies (11 papers), Nosocomial Infections in ICU (10 papers), Pneumonia and Respiratory Infections (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.6k citations), Molecular Medicine (1.4k citations) and Critical Care and Intensive Care Medicine (498 citations). Luke Moore has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Alison Holmes, Timothy M. Rawson, Philippe J. Guérin, Laura J. V. Piddock, Abhilasha Karkey, Sadie Regmi, Arnfinn Sundsfjord, Martin Steinbakk, Mark Gilchrist and Nabeela Mughal. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Clinical Microbiology and Infection, BMC Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.